# Showa Corporation

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/showa-corporation/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 72 |
| Citations | 17,560 |
| City | Gyōda |
| Country | JP |
| Description | Showa Corporation is a research organisation in Gyōda, JP. OpenAlex records 1,041 works and 17,560 citations for it. 356 researchers list it as their most recent affiliation. |
| Homepage | https://www.showa1.com/en/ |
| OpenAlex ID | https://openalex.org/I220323382 |
| Researchers | 356 |
| ROR ID | https://ror.org/02h39wj34 |
| Type | company |
| Wikidata ID | https://www.wikidata.org/wiki/Q3482588 |
| Works | 1,041 |

## University papers

- [Revised Equations for Estimated GFR From Serum Creatinine in Japan](https://scholariq.org/papers/revised-equations-for-estimated-gfr-from-serum-creatinine-in-japan/)
- [The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-rationale-clinicopathological/)
- [The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-pathology-definitions-correlations/)
- [IgA nephropathy](https://scholariq.org/papers/iga-nephropathy-2/)
- [Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity](https://scholariq.org/papers/aberrantly-glycosylated-iga1-in-iga-nephropathy-patients-is-recognized-by-igg/)
- [Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial](https://scholariq.org/papers/febuxostat-therapy-for-patients-with-stage-3-ckd-and-asymptomatic-hyperuricemia/)
- [The MEST score provides earlier risk prediction in lgA nephropathy](https://scholariq.org/papers/the-mest-score-provides-earlier-risk-prediction-in-lga-nephropathy/)
- [IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1](https://scholariq.org/papers/iga1-secreting-cell-lines-from-patients-with-iga-nephropathy-produce-aberrantly/)
- [Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy](https://scholariq.org/papers/autoantibodies-targeting-galactose-deficient-iga1-associate-with-progression-of/)
- [The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults](https://scholariq.org/papers/the-oxford-iga-nephropathy-clinicopathological-classification-is-valid-for/)
- [Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan](https://scholariq.org/papers/prognosis-and-risk-factors-for-idiopathic-membranous-nephropathy-with-nephrotic/)

## University top topics

Showing 8 of 22.

- [Physics of Superconductivity and Magnetism](https://scholariq.org/topics/physics-of-superconductivity-and-magnetism/)
- [Superconducting Materials and Applications](https://scholariq.org/topics/superconducting-materials-and-applications/)
- [High voltage insulation and dielectric phenomena](https://scholariq.org/topics/high-voltage-insulation-and-dielectric-phenomena/)
- [HVDC Systems and Fault Protection](https://scholariq.org/topics/hvdc-systems-and-fault-protection/)
- [Thermal Analysis in Power Transmission](https://scholariq.org/topics/thermal-analysis-in-power-transmission/)
- [Power Transformer Diagnostics and Insulation](https://scholariq.org/topics/power-transformer-diagnostics-and-insulation/)
- [Aluminum Alloy Microstructure Properties](https://scholariq.org/topics/aluminum-alloy-microstructure-properties/)
- [Aluminum Alloys Composites Properties](https://scholariq.org/topics/aluminum-alloys-composites-properties/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.